PREVENTION AND SCREENING FOR COVID 19 INFECTIOUS DISEASE IN THE CONDITIONS OF GENERAL PRACTICE

SARS-CoV-2 is the name of a new strain of coronavirus that was first reported in Wuhan City, the Chinese province of Hubei, in the middle of December 2019. The new viral disease has spread at an alarming rate worldwide, despite extreme anti-epidemic measures and strategies taken by many countries to...

Full description

Bibliographic Details
Main Author: S. Alekova
Format: Article
Language:English
Published: Trakia University 2020-12-01
Series:Trakia Journal of Sciences
Subjects:
Online Access:http://tru.uni-sz.bg/tsj/TJS%20-%20Suppl.1,%20Vol.18,%202020/42_S.Alekova.pdf
id doaj-d2805116545141bc8037918a3d1e3108
record_format Article
spelling doaj-d2805116545141bc8037918a3d1e31082021-04-07T08:31:03ZengTrakia UniversityTrakia Journal of Sciences1313-35512020-12-0118Suppl. 124124610.15547/tjs.2020.s.01.042PREVENTION AND SCREENING FOR COVID 19 INFECTIOUS DISEASE IN THE CONDITIONS OF GENERAL PRACTICES. AlekovaSARS-CoV-2 is the name of a new strain of coronavirus that was first reported in Wuhan City, the Chinese province of Hubei, in the middle of December 2019. The new viral disease has spread at an alarming rate worldwide, despite extreme anti-epidemic measures and strategies taken by many countries to limit the pandemic. Various activities of active and passive screening in the General practice have implemented to constrain the transamination of coronavirus infection. They involve a series of actions for informing and education of patients, early identification of suspected cases and management of patient with viral infection. To date, there is no approved vaccine or specific antiviral treatment available for COVID- 19. Further research is needed to understand in detail the life cycle of SARS-CoV-2, to detect the original source of the virus, to establish the mechanisms of transmission, as well as to develop effective methods for prevention of the onset of an infectious process and adequate treatment. It is necessary to be presented reliable scientific evidence that will contribute to more effective and quality screening in the General Practice. In this moment, all protective measures in the General medicine's office need to be focused on providing better protection for healthcare professionals and patients.http://tru.uni-sz.bg/tsj/TJS%20-%20Suppl.1,%20Vol.18,%202020/42_S.Alekova.pdfcoronavirus diseasepreventionscreeninggeneral practice
collection DOAJ
language English
format Article
sources DOAJ
author S. Alekova
spellingShingle S. Alekova
PREVENTION AND SCREENING FOR COVID 19 INFECTIOUS DISEASE IN THE CONDITIONS OF GENERAL PRACTICE
Trakia Journal of Sciences
coronavirus disease
prevention
screening
general practice
author_facet S. Alekova
author_sort S. Alekova
title PREVENTION AND SCREENING FOR COVID 19 INFECTIOUS DISEASE IN THE CONDITIONS OF GENERAL PRACTICE
title_short PREVENTION AND SCREENING FOR COVID 19 INFECTIOUS DISEASE IN THE CONDITIONS OF GENERAL PRACTICE
title_full PREVENTION AND SCREENING FOR COVID 19 INFECTIOUS DISEASE IN THE CONDITIONS OF GENERAL PRACTICE
title_fullStr PREVENTION AND SCREENING FOR COVID 19 INFECTIOUS DISEASE IN THE CONDITIONS OF GENERAL PRACTICE
title_full_unstemmed PREVENTION AND SCREENING FOR COVID 19 INFECTIOUS DISEASE IN THE CONDITIONS OF GENERAL PRACTICE
title_sort prevention and screening for covid 19 infectious disease in the conditions of general practice
publisher Trakia University
series Trakia Journal of Sciences
issn 1313-3551
publishDate 2020-12-01
description SARS-CoV-2 is the name of a new strain of coronavirus that was first reported in Wuhan City, the Chinese province of Hubei, in the middle of December 2019. The new viral disease has spread at an alarming rate worldwide, despite extreme anti-epidemic measures and strategies taken by many countries to limit the pandemic. Various activities of active and passive screening in the General practice have implemented to constrain the transamination of coronavirus infection. They involve a series of actions for informing and education of patients, early identification of suspected cases and management of patient with viral infection. To date, there is no approved vaccine or specific antiviral treatment available for COVID- 19. Further research is needed to understand in detail the life cycle of SARS-CoV-2, to detect the original source of the virus, to establish the mechanisms of transmission, as well as to develop effective methods for prevention of the onset of an infectious process and adequate treatment. It is necessary to be presented reliable scientific evidence that will contribute to more effective and quality screening in the General Practice. In this moment, all protective measures in the General medicine's office need to be focused on providing better protection for healthcare professionals and patients.
topic coronavirus disease
prevention
screening
general practice
url http://tru.uni-sz.bg/tsj/TJS%20-%20Suppl.1,%20Vol.18,%202020/42_S.Alekova.pdf
work_keys_str_mv AT salekova preventionandscreeningforcovid19infectiousdiseaseintheconditionsofgeneralpractice
_version_ 1721536233433202688